Covidien Plans to Spin off Pharma Business, Including Its API Business
12:12 PM | December 19, 2011 | Deepti Ramesh
Covidien (Dublin) says it plans to spin off its pharmaceuticals business into a standalone public company. “The spin off includes the company’s active pharmaceutical ingredients (API) business, which...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.